Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Last Close
94.57
Jul 01 • 04:00PM ET Dollar change+1.12 Percentage change(1.20%)
Index
RUT
Market Cap
3.21B
Enterprise Value
4.58B
Income
141.80M
Sales
1.85B
Book/sh
49.99
Cash/sh
0.24
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
11000
IPO
Sep 29, 2000
P/E
23.57
Forward P/E
13.89
PEG
3.19
P/S
1.73
P/B
1.89
P/C
395.46
P/FCF
32.18
EV/EBITDA
13.57
EV/Sales
2.48
Quick Ratio
2.38
Current Ratio
3.75
Debt/Eq
0.81
LT Debt/Eq
0.81
Option/Short
Yes / Yes
EPS (ttm)
4.01
EPS next Y
6.81
EPS next Q
1.38
EPS this Y
-4.96%
EPS next Y
11.92%
EPS next 5Y
4.36%
EPS past 3/5Y
13.83% 4.37%
Sales past 3/5Y
10.24% 11.47%
EPS Y/Y TTM
77.43%
Sales Y/Y TTM
5.48%
EPS Q/Q
172.16%
Sales Q/Q
1.13%
Insider Own
1.28%
Insider Trans
-0.19%
Inst Own
115.59%
Inst Trans
7.59%
ROA
4.23%
ROE
8.58%
ROIC
4.62%
Gross Margin
23.16%
Oper. Margin
10.92%
Profit Margin
7.66%
SMA20
3.02%
SMA50
5.94%
SMA200
10.46%
Trades
Shs Outstand
33.95M
Shs Float
33.52M
52W High
123.49 -23.42%
52W Low
62.00 52.53%
Volatility
2.84% 2.64%
ATR (14)
2.73
RSI (14)
59.80
Beta
0.64
Rel Volume
0.75
Avg Volume
523.82K
Volume
392,337
Perf Week
3.49%
Perf Month
4.89%
Perf Quarter
7.47%
Perf Half Y
20.43%
Perf YTD
20.58%
Perf Year
-22.03%
Perf 3Y
6.73%
Perf 5Y
-0.58%
Perf 10Y
195.53%
Prev Close
93.45
Price
94.57
Change
1.20%
Date Action Analyst Rating Change Price Target Change
May-13-26Upgrade Oppenheimer Perform → Outperform $115
Feb-20-26Upgrade The Benchmark Company Hold → Buy $95
Oct-24-25Downgrade Wells Fargo Overweight → Equal Weight $80
Oct-24-25Downgrade The Benchmark Company Buy → Hold
Oct-24-25Downgrade Citigroup Buy → Neutral $77
Oct-24-25Downgrade BofA Securities Buy → Neutral $87
Oct-24-25Downgrade Argus Buy → Hold
May-22-25Upgrade Citigroup Neutral → Buy $140
Mar-28-25Initiated Raymond James Outperform $145
Feb-21-25Downgrade Oppenheimer Outperform → Perform
Jun-03-26 08:00AM
May-15-26 06:26PM
May-01-26 08:30AM
Apr-30-26 08:13AM
08:00AM
08:00AM Loading…
08:00AM
Apr-29-26 08:00AM
Apr-06-26 05:00PM
Apr-02-26 08:00AM
Mar-12-26 08:00AM
Mar-06-26 10:13AM
Feb-26-26 11:32PM
12:35AM
Feb-24-26 08:00AM
Feb-23-26 12:07PM
12:00PM Loading…
Feb-20-26 12:00PM
11:44AM
12:34AM
Feb-19-26 04:01PM
12:32PM
12:05PM
10:00AM
09:15AM
08:31AM
08:11AM
08:00AM
Feb-17-26 10:04PM
Feb-12-26 05:30PM
Jan-28-26 09:00AM
08:00AM
07:29AM Loading…
Jan-23-26 07:29AM
Jan-22-26 11:08AM
08:00AM
Jan-18-26 11:07PM
Jan-16-26 02:52AM
Jan-14-26 08:00AM
02:43AM
Jan-13-26 09:06AM
Jan-09-26 09:00AM
Jan-06-26 09:00AM
Dec-29-25 01:34AM
Dec-28-25 11:34PM
Dec-22-25 07:00AM
Dec-19-25 09:00AM
Dec-17-25 05:00PM
Nov-18-25 08:00AM
Nov-10-25 04:27AM
Nov-04-25 08:00AM
Oct-30-25 01:36AM
Oct-27-25 09:45AM
Oct-25-25 08:30AM
Oct-24-25 01:53PM
09:56AM
09:34AM
09:18AM
09:00AM
08:00AM
Oct-23-25 03:50PM
03:08PM
11:29AM
09:30AM
09:20AM
09:15AM
08:34AM
08:17AM
08:00AM
Oct-21-25 11:07PM
Oct-13-25 11:40AM
05:34AM
Oct-10-25 11:04AM
12:02AM
Oct-07-25 12:00PM
09:40AM
Oct-03-25 09:40AM
Sep-26-25 11:40AM
Sep-25-25 08:00AM
Sep-24-25 11:31PM
Sep-19-25 09:40AM
Sep-18-25 10:42AM
Sep-15-25 12:35AM
Sep-10-25 11:40AM
Sep-02-25 04:26PM
10:36AM
09:55AM
Sep-01-25 09:40AM
Aug-22-25 01:56PM
05:04AM
Aug-21-25 10:39AM
Aug-19-25 11:40AM
Aug-15-25 09:40AM
Aug-12-25 08:00AM
Aug-04-25 09:37AM
Jul-29-25 11:40AM
09:40AM
Jul-25-25 12:23PM
07:02AM
Jul-24-25 01:05PM
09:15AM
08:32AM
08:00AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
CEOMr. Payman Khales
Executive VP & CFOMr. Diron Smith
Senior VPMs. Lindsay Krause Blackwood J.D.
President of Cardio & VascularMr. Andrew Senn
President of Cardiac Rhythm Management & NeuromodulationMr. Jim Stephens
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stephens JimPresident, CRM & NeuroMay 15 '26Option Exercise0.001,96306,331May 19 04:28 PM
Smith DironEVP, Chief Financial OfficerMay 08 '26Option Exercise0.002,063013,422May 12 06:00 PM
Thomas Tommy PVP, Corporate ControllerMar 13 '26Sale85.0082570,1254,381Mar 17 05:15 PM
BAILEY PAMELA GDirectorJan 02 '26Option Exercise48.432,883139,62456,052Jan 05 07:29 PM
MAXWELL MARTIN CDirectorDec 12 '25Option Exercise48.432,883139,62425,053Dec 16 07:20 PM
Harris John AEVP, Global Ops and ManufacturNov 12 '25Buy70.001,650115,5006,066Nov 13 04:18 PM
Thomas Tommy PVP, Corporate ControllerNov 11 '25Sale70.1588462,0133,596Nov 13 08:12 AM
Smith DironEVP, Chief Financial OfficerNov 07 '25Buy67.191,11674,9677,698Nov 10 08:19 AM
Capps Cheryl CDirectorNov 06 '25Buy66.701,600106,72011,702Nov 10 08:16 AM
Khales PaymanPresident & CEOOct 30 '25Buy64.943,127203,06722,865Oct 30 04:05 PM